{"transactions":[{"id":4160497,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2017-11-17T00:46:42.000Z","date":"2017-11-16","kind":"tax_withholding","acquired":false,"shares":5625,"price":1.4702,"value":8269.875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,946,609 shares of common stock."}],"balance_after":876609,"source":{"system":"sec-edgar","filing":"0001209191-17-061324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117061324/doc4.xml","form_type":"4"}},{"id":4230751,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2017-08-17T20:49:26.000Z","date":"2017-08-16","kind":"tax_withholding","acquired":false,"shares":8469,"price":2.06,"value":17446.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,952,234 shares of common stock."}],"balance_after":882234,"source":{"system":"sec-edgar","filing":"0001209191-17-049422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117049422/doc4.xml","form_type":"4"}},{"id":4270162,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2017-06-29T21:13:32.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares represent a grant of Restricted Stock Units (\"RSUs\").  The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price.  The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,960,703 shares of common stock."}],"balance_after":890703,"source":{"system":"sec-edgar","filing":"0001209191-17-042350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117042350/doc4.xml","form_type":"4"}},{"id":4315800,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2017-05-17T23:07:59.000Z","date":"2017-05-16","kind":"tax_withholding","acquired":false,"shares":1263,"price":2.8621,"value":3614.8323,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David continues to beneficially own or have a right to acquire 1,770,703 shares of common stock."}],"balance_after":700703,"source":{"system":"sec-edgar","filing":"0001209191-17-033415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117033415/doc4.xml","form_type":"4"}},{"id":4436093,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2017-02-21T22:59:17.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":1390,"price":2.95,"value":4100.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David continues to beneficially own or have a right to acquire 1,771,966 shares of common stock."}],"balance_after":701966,"source":{"system":"sec-edgar","filing":"0001209191-17-012847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117012847/doc4.xml","form_type":"4"}},{"id":4548747,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":171854,"kind":"person","name":"David Eric","position":1,"cik":"0001549671","reported_name":"David Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO & EVP Pre-Clinical Dev"}}],"security":"Common Stock","published_at":"2016-11-18T22:06:19.000Z","date":"2016-11-16","kind":"tax_withholding","acquired":false,"shares":1745,"price":3.2594,"value":5687.653,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David continues to beneficially own or have a right to acquire 1,773,356 shares of common stock."}],"balance_after":703356,"source":{"system":"sec-edgar","filing":"0001209191-16-151268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919116151268/doc4.xml","form_type":"4"}}]}